• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    14.33 Up 1.09(8.23%) Feb 5, 3:59PM EST
    |After Hours : 14.33 0.00 (0.00%) Feb 5, 4:49PM EST
    Prev Close:13.24
    Open:13.48
    Bid:13.35 x 300
    Ask:N/A
    1y Target Est:38.67
    Beta:1.71
    Earnings Date:Mar 21 - Mar 25 (Est.)
    Day's Range:13.35 - 15.28
    52wk Range:12.17 - 38.10
    Volume:809,999
    Avg Vol (3m):290,300
    Market Cap:557.34M
    P/E (ttm):N/A
    EPS (ttm):-6.18
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CHRS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-6.51
    Quarterly EPS Est (Mar-15) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback